Wissen teilen, Fortschritt sichern

Publikationen aus der Diagnostik und Forschung

Entdecken Sie unsere wissenschaftlichen Veröffentlichungen – fundiert, praxisnah und richtungsweisend.

BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy

BRAF funktionale Klassen, BRAF mutation functional class, BRAF mutation subtype, BRAF zielgerichtete Therapie, BRAF-Mutated lung cancer, BRAF-Mutationssubtypen, BRAF-mutiertes Lungenkarzinom, BRAF-Targeted therapy,, NSCLC immunotherapy, NSCLC Immuntherapie

Wiesweg M, Preuß C, Roeper J, Metzenmacher M, Eberhardt W, Stropiep U, et al. BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy. Eur J Cancer 2021 May; DOI: 10.1016/j.ejca.2021.02.036

Identification of CTLA-4-Positive Cells in the Human Tonsil

antibodies, Antikörper, CTLA-4, immunophenotyping, Immunphänotypisierung, T-cell activation, T-lymphocytes, T-Lymphozyten, T-Zell Aktivierung, tonsil, Tonsille

Tiemann M, et al. Identification of CTLA-4-Positive Cells in the Human Tonsil. Cells 2021 Apr 27;10(5):1027. doi: 10.3390/cells10051027

Protein Phosphatase 2A Improves Cardiac Functional Response to Ischemia and Sepsis

Heart, Herz, Ischämie, ischemia, LPS, PP2A, protein phosphorylation, Protein Phosphorylierung, Sepsis, Transgene Mäuse, transgenic mice

Gergs U, et al. Protein Phosphatase 2A Improves Cardiac Functional Response to Ischemia and Sepsis. Int J Mol Sci 2021 Apr 23;23(9):4688. doi.org/10.3390/ijms23094688

Extracellular Vesicles and Their Role in the Spatial and Temporal Expansion of Tumor–Immune Interactions

angeborene Immunantwort, diagnostics, Diagnostik, extracellular vesicle, Extrazelluläre Vesikel, innate immune responses, Liquid Biopsy, microbiome, Mikrobiom, PD-L1, physical activity, physische Aktivität, tumor evolution, Tumor-Evolution, Tumor–Immun-Mikromilieu, tumor–immune microenvironment

Lipinski S, Tiemann K, Extracellular Vesicles and Their Role in the Spatial and Temporal Expansion of Tumor–Immune Interactions. Int J Mol Sci 2021 Apr;22(7): 3374. doi: 10.3390/ijms22073374

Neue Indikation PIK3CA-mutiertes Mammakarzinom: Erste Erfahrungen aus dem molekularpathologischen Routinelabor

Mamma carcinoma, Mammakarzinom myoepitheliale Differenzierung, next generation sequencing (NGS), Next-Generation Sequencing (NGS), PIK3CA

Strohkamp S, Schmidt S, Falk M, Tiemann K. Neue Indikation PIK3CA-mutiertes Mammakarzinom: Erste Erfahrungen aus dem molekularpathologischen Routinelabor. Journal Oncologie 2021

Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model Study

Artefacte, artifacts, artificial intelligence, clinical pathology, convolutional neural networks, deep learning, digital pathology, digitale Pathologie, künstliche Intelligenz, machine learning, Maschinelles Lernen, neural networks, Neuronale Netzwerke, Pathologie, pathology, pitfalls

Schmitt M, et al .Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model Study. J Med Internet Res 2021 Feb 2;23(2):e23436. doi: 10.2196/23436

Twenty-Eight Cases of Extraocular Sebaceous Carcinoma: A Correlative Clinicopathological and Immunohistochemical Analysis of Extraocular Sebaceous Carcinomas and Benign Sebaceous Gland Tumors.

Boecker W, et al. Twenty-Eight Cases of Extraocular Sebaceous Carcinoma: A Correlative Clinicopathological and Immunohistochemical Analysis of Extraocular Sebaceous Carcinomas and Benign Sebaceous Gland Tumors. Am J Dermatopathol 2021 Feb 1;43(2):93-102. doi: 10.1097/DAD.0000000000001667

TP53 mutations as AN independent prognostic factor in 2nd AND FURTHER line THERAPY – EGFR mutated Non-Small Cell Lung Cancer IV PATIENTS treated with Osimertinib

EGFR, NSCLC, Osimertinib, TKI, TP53 Mutation

Roeper J, et al. TP53 mutations as AN independent prognostic factor in 2nd AND FURTHER line THERAPY – EGFR mutated Non-Small Cell Lung Cancer IV PATIENTS treated with Osimertinib. Transl Lung Cancer Res 2021 Jan;11(1):4-13. doi: 10.21037/tlcr-21-754

Initial Characterization of Stressed Transgenic Mice With Cardiomyocyte-Specific Overexpression of Protein Phosphatase 2C

Entzündung, Fibrose, fibrosis, heart failure, Herzversagen, inflammation, PP2A, PP2C, Transgene Mäuse, transgenic mice

Bollmann P, et al. Initial Characterization of Stressed Transgenic Mice With Cardiomyocyte-Specific Overexpression of Protein Phosphatase 2C. Front Pharmacol 2021 Jan 11;11:591773. DOI: 10.3389/fphar.2020.591773

Risk stratification of EGFR + lung cancer diagnosed with panel-based next-generation sequencing

Adenokarzinom der Lunge EGFR, lung adenocarcinoma, next generation sequencing (NGS), Next-Generation Sequencing (NGS), non small cell lung cancer (NSCLC), NSCLC, TP53, tyrosine kinase inhibitor (TKI), yrosinekinaseinhibitor (TKI)

Christopoulos P, et al. Risk stratification of EGFR + lung cancer diagnosed with panel-based next-generation sequencing. Lung Cancer 2020 Oct;148:105-112. doi: 10.1016/j.lungcan.2020.08.007